INTECH Investment Management’s SpringWorks Therapeutics SWTX Stock Holding History

INTECH Investment Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-48,298	Closed	-$2.27M	–	2521
2025 Q2	$2.27M	Buy	48,298 +5,787	+14%	+$257K	0.02%	685
2025 Q1	$1.88M	Buy	42,511 +18,318	+76%	+$843K	0.02%	788
2024 Q4	$874K	Buy	24,193 +3,109	+15%	+$109K	0.01%	1234
2024 Q3	$676K	Buy	+21,084	New	+$788K	0.01%	1051

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

INTECH Investment Management's SWTX Position: Q3 2025 in Review

INTECH Investment Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 48,298 shares — an estimated $2.27M sold.

INTECH Investment Management first reported a position in SWTX in Q3 2024 and held it in 4 quarters. The position peaked at $2.27M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

INTECH Investment Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
INTECH Investment Management sold 48,298 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.27M.
INTECH Investment Management first reported a position in SpringWorks Therapeutics in Q3 2024 and held it in 4 quarters.
INTECH Investment Management's SpringWorks Therapeutics position peaked at $2.27M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on INTECH Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.